Remove Generic Medicine Remove Insurance Remove Patient Care
article thumbnail

How could tariffs impact the pharmaceutical industry?

European Pharmaceutical Review

The US imports a substantial volume of APIs and finished medicines, many of which are essential for patient care, meaning these tariffs could have far-reaching implications. However, in the long term, increased costs could be passed on to healthcare systems, insurers, and ultimately, patients.